AstraZeneca has committed to becoming carbon negative by 2030.
The pharmaceutical giant has stepped up its existing science-based targets to aim for the ambitious goal - it plans to double energy productivity, decarbonise heat and power with renewable electricity and switch to a fleet of electric vehicles (EVs) five years earlier than it originally scheduled.
The firm aims to invest up to $1bn (£764m) to achieve these goals.
future Net Zero is a free site but we’d ask you to login one time to access the content.
You will also be subscribed to our newsletter service, which will offer insight and editorial commentary, you are free to unsubscribe at anytime.
You can sign up using:
Or simply create an account